Breaking News Instant updates and real-time market news.

GILD

Gilead

$63.57

0.75 (1.19%)

11:48
04/25/19
04/25
11:48
04/25/19
11:48

Piper Jaffray 'not shocked at all' by Gilead's STELLAR3 whiff

Piper Jaffray analyst Tyler Van Buren says he is "not shocked at all" by Gilead's STELLAR3 whiff given the prior failure of STELLAR4. With that said, the fact that placebo outperformed selonsertib was particularly unfortunate and suggests that the compound is all but dead, unless the company can revive it via combination strategies, he contends. The analyst believes this further emphasizes the fact that Gilead's pipeline "does not pack enough punch" for a company of its size. Van Burren reiterates a Neutral rating and a $75 price target on the shares.

  • 28

    Apr

  • 02

    May

  • 03

    May

  • 06

    May

  • 08

    May

  • 18

    May

GILD Gilead
$63.57

0.75 (1.19%)

03/15/19
03/15/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Simmons First National (SFNC) initiated with a Buy at DA Davidson. 2. Amgen (AMGN) and Gilead (GILD) initiated with an Outperform at BMO Capital. 3. Rocket Pharmaceuticals (RCKT) initiated with a Buy at BofA/Merrill. 4. Urovant Sciences (UROV) initiated with a Buy at SunTrust. 5. Spectrum (SPPI) assumed with a Buy at Jefferies. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
03/17/19
PIPR
03/17/19
NO CHANGE
Target $75
PIPR
Neutral
Gilead HIV drugs' price increase 30% lower than prior years, says Piper Jaffray
Piper Jaffray analyst Tyler Van Buren notes that as expected, effective March 16th, Gilead raised list prices of the company's top 6 selling HIV antiviral drugs by 4.9% which includes Atripla, Biktarvy, Descovy, Genvoya, Odefsey, and Truvada. Notably, the price increases were roughly 30% lower than what has been observed in prior years and likely reflects the recent increasing pressure on drug pricing, he contends. The analyst also notes that these increases are well below the high single digit year over year price increases that have been observed with other companies, which Gilead can afford due to strong volume growth of its next generation TAF-based regimens. Van Buren reiterates a Neutral rating and $75 price target on the shares.
04/10/19
UBSW
04/10/19
UPGRADE
Target $77
UBSW
Buy
Gilead upgraded to Buy from Neutral at UBS
UBS analyst Carter Gould upgraded Gilead Sciences to Buy from Neutral and raised his price target for the shares to $77 from $75. Following the failure of selonsertib in nonalcoholic steatohepatitis, Gilead announced "two important clinical wins" in the positive Descovy PrEP data and filgotinib Finch1/3 data, Gould tells investors in a research note. These unlock two $2B-plus revenue opportunities and go "far to de-risk" the company's growth in 2021 and beyond, contends the analyst. Further, while the analyst expects a Q1 earnings miss, he believes 2019 estimates will move higher as NASH precommercialization spend likely comes out of guidance.
04/12/19
RBCM
04/12/19
NO CHANGE
RBCM
Outperform
Intercept's OCA risk-benefit profile still looks solid, says RBC Capital
RBC Capital analyst Brian Abrahams kept his Outperform rating on Intercept (ICPT) after its Regenerate data in the 25mg obeticholic acid, or OCA, study and the subsequent 13% decline in its stock price. The analyst believes that the sell-off was in part a "sell the news" event and also may have been driven by the separately announced 20% sales force layoff at Gilead (GILD), which had been viewed as a potential buyer of NASH assets. Abrahams maintains his view on OCA's benefit/risk profile as "solid", adding that while fundamental concerns around the launch and necessary capital are likely to remain, he expects its "likely approval and broad long-term market opportunity" to become "better appreciated in the medium-term."

TODAY'S FREE FLY STORIES

S

Sprint

$7.50

0.04 (0.54%)

, TMUS

T-Mobile

$78.88

0.6 (0.77%)

09:48
06/20/19
06/20
09:48
06/20/19
09:48
Periodicals
T-Mobile, Sprint highly likely to receive DOJ approval, CNBC reports »

T-Mobile (TMUS) and…

S

Sprint

$7.50

0.04 (0.54%)

TMUS

T-Mobile

$78.88

0.6 (0.77%)

DISH

Dish

$39.51

0.61 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUK

Carnival plc

$45.66

-6.08 (-11.75%)

09:47
06/20/19
06/20
09:47
06/20/19
09:47
Hot Stocks
Carnival plc falls -11.6% »

Carnival plc is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

PIR

Pier 1 Imports

$11.89

11.2159 (1,663.83%)

09:47
06/20/19
06/20
09:47
06/20/19
09:47
Hot Stocks
Pier 1 Imports falls -12.3% »

Pier 1 Imports is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

JDST

Direxion Daily Junior Gold Miners Index Bear 3x Shares

$29.80

-4.41 (-12.89%)

09:47
06/20/19
06/20
09:47
06/20/19
09:47
Hot Stocks
Direxion Daily Junior Gold Miners Index Bear 3x Shares falls -12.9% »

Direxion Daily Junior…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IAG

IAMGold

$3.36

0.35 (11.63%)

09:47
06/20/19
06/20
09:47
06/20/19
09:47
Hot Stocks
IAMGold rises 12.0% »

IAMGold is up 12.0%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZNH

China Southern Airlines

$35.85

2.24 (6.66%)

09:47
06/20/19
06/20
09:47
06/20/19
09:47
Hot Stocks
China Southern Airlines rises 7.4% »

China Southern Airlines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$10.99

1.29 (13.30%)

09:47
06/20/19
06/20
09:47
06/20/19
09:47
Hot Stocks
Direxion Daily Jr Gld Mnrs Bull 3X Shrs rises 12.8% »

Direxion Daily Jr Gld…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZSAN

Zosano Pharma

$3.07

(0.00%)

09:45
06/20/19
06/20
09:45
06/20/19
09:45
Conference/Events
Zosano Pharma management to meet with Maxim »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 25

    Jun

09:45
06/20/19
06/20
09:45
06/20/19
09:45
General news
Leading Indicators to be reported at 10:00 »

May Leading Indicators…

S

Sprint

$7.46

(0.00%)

, TMUS

T-Mobile

$78.28

(0.00%)

09:44
06/20/19
06/20
09:44
06/20/19
09:44
Periodicals
Breaking Periodicals news story on Sprint, T-Mobile »

Sprint, T-Mobile highly…

S

Sprint

$7.46

(0.00%)

TMUS

T-Mobile

$78.28

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PHUN

Phunware

$3.50

(0.00%)

09:44
06/20/19
06/20
09:44
06/20/19
09:44
Hot Stocks
Phunware says Phun utility tokens now available in select international markets »

Phunware announced Phun…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WYND

Wyndham Destinations

$43.19

(0.00%)

09:43
06/20/19
06/20
09:43
06/20/19
09:43
Conference/Events
Wyndham Destinations management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

VKTX

Viking Therapeutics

$8.22

(0.00%)

09:41
06/20/19
06/20
09:41
06/20/19
09:41
Conference/Events
Viking Therapeutics management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

EVBG

Everbridge

$91.34

(0.00%)

09:40
06/20/19
06/20
09:40
06/20/19
09:40
Recommendations
Everbridge analyst commentary  »

Everbridge price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AOBC

American Outdoor Brands

$9.17

(0.00%)

, MLNT

Melinta Therapeutics

$6.30

(0.00%)

09:40
06/20/19
06/20
09:40
06/20/19
09:40
Options
Unusually active option classes on open June 20th »

Unusual total active…

AOBC

American Outdoor Brands

$9.17

(0.00%)

MLNT

Melinta Therapeutics

$6.30

(0.00%)

PAAS

Pan American Silver

$11.78

(0.00%)

AUY

Yamana Gold

$2.23

(0.00%)

GDXJ

VanEck Vectors Junior Gold Miners

$32.36

(0.00%)

ESV

Ensco Rowan

$7.35

(0.00%)

NEM

Newmont Mining

$36.36

(0.00%)

KR

Kroger

$23.64

(0.00%)

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$9.70

(0.00%)

XLNX

Xilinx

$111.85

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 27

    Jun

  • 09

    Jul

UPS

UPS

$101.55

(0.00%)

09:40
06/20/19
06/20
09:40
06/20/19
09:40
Conference/Events
UPS management to meet with KeyBanc »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 24

    Jul

CBS

CBS

$49.72

0.51 (1.04%)

, VIA

Viacom

$35.68

0.85 (2.44%)

09:39
06/20/19
06/20
09:39
06/20/19
09:39
Periodicals
CBS, Viacom expect merger deal in near term, CNBC's Faber reports »

While CBS (CBS) and…

CBS

CBS

$49.72

0.51 (1.04%)

VIA

Viacom

$35.68

0.85 (2.44%)

VIAB

Viacom

$30.46

0.65 (2.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

VTR

Ventas

$69.65

1.05 (1.53%)

09:37
06/20/19
06/20
09:37
06/20/19
09:37
Recommendations
Ventas analyst commentary  »

Ventas price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBS

CBS

$49.72

0.51 (1.04%)

, VIA

Viacom

$35.68

0.85 (2.44%)

09:37
06/20/19
06/20
09:37
06/20/19
09:37
Periodicals
Breaking Periodicals news story on CBS, Viacom, Viacom »

CBS, Viacom not…

CBS

CBS

$49.72

0.51 (1.04%)

VIA

Viacom

$35.68

0.85 (2.44%)

VIAB

Viacom

$30.46

0.65 (2.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

TSLX

TPG Specialty Lending

$20.20

0.24 (1.20%)

09:37
06/20/19
06/20
09:37
06/20/19
09:37
Conference/Events
TPG Specialty Lending management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

CCL

Carnival

$52.85

0.46 (0.88%)

, NCLH

Norwegian Cruise Line

$53.91

0.18 (0.34%)

09:34
06/20/19
06/20
09:34
06/20/19
09:34
Downgrade
Carnival, Norwegian Cruise Line, Royal Caribbean rating change  »

William Blair downgrades…

CCL

Carnival

$52.85

0.46 (0.88%)

NCLH

Norwegian Cruise Line

$53.91

0.18 (0.34%)

RCL

Royal Caribbean

$122.65

0.02 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

NFLX

Netflix

$363.61

6.49 (1.82%)

, DIS

Disney

$140.89

1.68 (1.21%)

09:33
06/20/19
06/20
09:33
06/20/19
09:33
Initiation
Netflix, Disney initiated  »

Netflix initiated with an…

NFLX

Netflix

$363.61

6.49 (1.82%)

DIS

Disney

$140.89

1.68 (1.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 17

    Jul

TITN

Titan Machinery

$17.86

0.33 (1.88%)

09:33
06/20/19
06/20
09:33
06/20/19
09:33
Conference/Events
Titan Machinery management to meet with Craig-Hallum »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 13

    Nov

JSYN

Jensyn Acquisition

$0.00

(0.00%)

, PECK

Peck

$5.00

-5.02 (-50.10%)

09:30
06/20/19
06/20
09:30
06/20/19
09:30
Hot Stocks
Jensyn Acquisition completes business combination with Peck Electric »

Jensyn Acquisition Corp…

JSYN

Jensyn Acquisition

$0.00

(0.00%)

PECK

Peck

$5.00

-5.02 (-50.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSU

Tim Participacoes

$14.90

0.485 (3.37%)

09:30
06/20/19
06/20
09:30
06/20/19
09:30
Upgrade
Tim Participacoes rating change  »

Tim Participacoes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.